BDSX Q3 2022 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$11M+70.1% YoY

Gross Profit

$7M67.3% margin

Operating Income

-$11M-95.5% margin

Net Income

-$14M-123.3% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$63M

Total Liabilities

$66M

Stockholders' Equity

-$3M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+70.1%
Gross Profit	$7M	$4M	+96.2%
Operating Income	-$11M	-$13M	+19.0%
Net Income	-$14M	-$12M	-19.0%

Revenue Segments

Diagnostic Tests

$10M94%

Service

$664,0006%